Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
180
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Genfit - ADR market cap is $446.03M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genfit - ADR 52 week high is $10.20 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genfit - ADR 52 week low is $2.55 as of November 22, 2026.
Genfit - ADR stock price today is $0.0207.
Genfit - ADR stock price yesterday was $0.0199.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Genfit - ADR's P/E ratio is -10.6.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Genfit - ADR P/B ratio is 7.2918.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Genfit - ADR 50-day moving average is $7.31.